Search

Author/Creator Isakoff, Steven J

1. A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. (February 2017)

Authors:
Isakoff, Steven J; Puhalla, Shannon; Domchek, Susan M; Friedlander, Michael; Kaufman, Bella; Robson, Mark; Telli, Melinda L; Diéras, Véronique; Han, Hyo Sook; Garber, Judy E; Johnson, Eric F; Maag, David; Qin, Qin; Giranda, Vincent L; Shepherd, Stacie P
Journal:
Future oncology
Issue:
Volume 13:Number 4(2017)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10 (October 2017)

Authors:
Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espié, Marc; Blau, Sibel; Tan, Antoinette R; Isakoff, Steven J; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J; Kapp, Amy V; Chan, Wai Y; Singel, Stina M; Maslyar, Daniel J; Baselga, José
Journal:
Lancet oncology
Issue:
Volume 18:Issue 10(2017:Oct.)
Page Start:
1360
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. (December 2021)

Authors:
Beyerlin, Kassidy; Jimenez, Rachel; Zangardi, Mark; Fell, Geoffrey G; Edmonds, Christine; Johnson, Andrew; Bossuyt, Veerle; Specht, Michelle; Mulvey, Therese M; Moy, Beverly; Ellisen, Leif W; Isakoff, Steven J; Bardia, Aditya; Spring, Laura M
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 27:Number 8(2021)
Page Start:
1883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗